Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-70.81	10.21	34.97
Graham Fair Price	41.42	1.16	0.82
PEG	-48.39	-0.03	0.06
Price/Book	-17.19	0.26	0.32
Price/Cash Flow	-33.53	6.53	9.82
Prices/Earnings	58.59	-3.18	-7.68
Price/Sales	-58.59	0.12	0.29
Price/FCF	-33.53	6.53	9.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-50.00	0.50	1.00
Operating Margin	-71.43	< 0.005	< 0.005
ROA	-100.00	< 0.005	< 0.005
ROE	-0.01	-0.02	-100.00
ROIC	< 0.005	< 0.005	-60.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.15	-0.17	-12.17
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.91	-0.43	52.80
EPS QOQ	-1.25	-1.00	19.78
FCF QOQ	-0.30	0.25	-17.72
Revenue QOQ	-0.59	1.00	70.29
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	67.69	100.00
Days Sales Outstanding (DSO)	31.20	15.69	-49.72
Inventory Turnover	0.00	1.33	100.00
Debt/Capitalization	0.39	0.42	8.43
Quick Ratio	0.29	0.29	0.49
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.70	1.70	< 0.005
Cash	0.08	0.08	< 0.005
Capex	-0.01	-0.03	-100.00
Free Cash Flow	0.06	0.07	24.59
Revenue	1.88	3.75	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.86	0.86	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.62	7.34	-67.54
Naive Interpretation	Member

06 - Financial Health · Bad

Rating